在新辅助化疗 (KSCC1301-A2) 后的直肠癌免疫检查点状态和瘤基因突变概况
Yu Miyashita1,2, Eiji Oki1, Tomohiro Kamori1
1Department of Surgery and Science, Graduate School of Medical Science Kyushu University Fukuoka Japan.
Annals of gastroenterological surgery
|March 8, 2024
概括
新辅助化疗 (NAC) 通过增加免疫检查点分子和瘤透性淋巴细胞,增强不匹配修复性直肠癌 (pMMR) 的瘤免疫微环境. 这表明pMMR直肠癌可能受益于联合免疫疗法和化疗.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 结肠直肠癌研究研究
背景情况:
- 免疫检查点抑制剂 (ICI) 在不匹配修复能力 (pMMR) 的结肠直肠癌 (CRCs) 中表现出有限的疗效,与缺乏MMR的CRC相比.
- 局部晚期直肠癌 (LARC) 是一个重大的临床挑战,pMMR亚型对当前的免疫疗法反应较差.
- 了解瘤微环境对新辅助化疗 (NAC) 的反应对于开发有效的pMMRCRC治疗策略至关重要.
研究的目的:
- 在新辅助化疗 (NAC) 后调查pMMR LARC瘤微环境的变化.
- 评估免疫检查点抑制剂 (ICI) 作为治疗pMMRCRC的治疗剂的潜力.
- 评估NAC后免疫检查点分子 (ICM) 和瘤透淋巴细胞 (TIL) 的变化.
主要方法:
- 一个随机二期试验 (KSCC1301) 的特设分析,涉及49名接受NAC (S-1/oxaliplatin或FU/folinic acid/oxaliplatin) 的LARC患者.
- 为了进行比较,包括了25名没有NAC手术的直肠癌患者的参考队列.
- 免疫组织化学用于评估ICMs (PD-1,PD-L1,CTLA-4,LAG3) 和TILs (CD8,FOXP3);下一代测序 (NGS) 在23名患者中进行.
主要成果:
- 与参考队列相比,在NAC组中观察到PD-1,CTLA-4和LAG3的显著更高的表达 (p < 0.001).
- 在NAC组中,CD8+和FOXP3+T细胞透率显著增加,CD8/FOXP3比率更高 (p < 0.0001).
- 在对NAC的反应中,NGS分析没有发现与TIL或ICM相关的特定基因变异.
结论:
- 新辅助化疗显著改变pMMR直肠癌中的瘤免疫微环境,增强免疫细胞透和检查点分子表达.
- 观察到的变化表明pMMR直肠癌可能对联合免疫疗法和化疗方案变得更敏感.
- 对组合疗法的进一步研究是有必要的,以改善pMMR LARC患者的治疗结果.
更多相关视频
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...


